Cumberland Pharmaceuticals (CPIX) Goodwill & Intangibles (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Goodwill & Intangibles across 17 years of filings, most recently posting $13.7 million for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $13.7 million, down 23.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.7 million (down 23.43% YoY), and the FY2025 annual result was $14.9 million, down 20.89% from the prior year.
• Goodwill & Intangibles came in at $13.7 million for Q1 2026 at Cumberland Pharmaceuticals, down from $14.9 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $36.4 million in Q1 2022 to a low of $13.7 million in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $22.4 million (2024), against an average of $24.0 million.
• Across the five-year window, Goodwill & Intangibles soared 30.48% in 2022 and fell 27.49% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Goodwill & Intangibles stood at $31.5 million in 2022, then retreated by 25.34% to $23.5 million in 2023, then declined by 19.7% to $18.9 million in 2024, then fell by 20.89% to $14.9 million in 2025, then dropped by 8.26% to $13.7 million in 2026.
• The last three Goodwill & Intangibles figures came in at $13.7 million (Q1 2026), $14.9 million (Q4 2025), and $15.9 million (Q3 2025), per Business Quant data.